Bringing the fundamentals into focus…
Back to Structure Therapeutics Inc.
How Structure Therapeutics Inc. stacks up
GPCR · against 445 other Healthcare companies of similar size
Profitability
24/ 100
Near the bottom of its peers.
Ranked #356 of 446 · scores higher than 20% of peers
Bars: peers in each 10-point band of the profitability score35 peers with a profitability score of 20–29, including GPCR · Click a bar to see the companies
Why profitability scores 24?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 79% of peers. Return on invested capital: -18.8% vs peer median 4.7%
- a lower return on assets: weaker than 78% of peers. Return on assets: -15.1% vs peer median 1.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = GPCR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | GPCR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 421 reported | -18.8% | 5.4% | 17% | 33% | |
| Operating marginHigher is better · 420 reported | Not reported | 7.1% | — | — | 33% |
| Return on assetsHigher is better · 432 reported | -15.1% | 1.9% | 19% | 33% | |
| Return on equityHigher is better · 416 reported | -20.2% | 3.4% | 22% | Context only | |
| Gross marginHigher is better · 462 reported | 0.0% | 47.6% | 2% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around GPCR| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 353 | 660M GBP (≈$858M) | 25 | 35 | |
| 353 | 2.0B USD | 25 | 53 | |
| 356 | 12.7B CNY (≈$1.8B) | 24 | 20 | |
| 356 | 775M USD | 24 | 31 | |
| 356 | 1.5B USD | 24 | 44 | |
| 356 | 2.0B USD | 24 | 42 | |
| 360 | 6.0B CNY (≈$841M) | 23 | 29 | |
| 360 | 6.8B CNY (≈$959M) | 23 | 43 | |
| 360 | 14.2B CNY (≈$2.0B) | 23 | 10 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score